or
forgot password
  • cancer clinical trials in berkeley, CA

  • Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Lymphoma
    Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma and Plasma Cell Neoplasm
    BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)
    University of California, School of Public Health, Childhood Leukemia Study
    Berkeley, California 94720-7392
    Leukemia, Acute Myelocytic Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia
    BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Pancreatic Cancer
    DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
    East Bay Region Associates in Neurology
    Berkeley, California 94705
    Multiple Sclerosis, Relapsing-Remitting
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Alta Bates Medical Center-Herrick Campus
    Berkeley, California 94704
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Head and Neck Cancer
    Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Androgen Independent Prostate Cancer (AIPC), Non Small Cell Lung Cancer (NSCLC)
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Gastrointestinal Stromal Tumor
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer
    Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Bortezomib, Cyclophosphamide, Dexamethasone, and Thalidomide in Treating Patients With Newly Diagnosed, Previously Untreated Multiple Myeloma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma and Plasma Cell Neoplasm
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Fatigue
    S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
    Alta Bates Comprehensive Cancer Centre
    Berkeley, California 94704
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Colorectal Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Provenge (TM) for the Treatment of Hormone Sensitive Prostate Cancer
    Alta Bates Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Extrahepatic Bile Duct Cancer, Gallbladder Cancer
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    East Bay Physicians Medical Group/ Sutter East Bay Medical Foundation
    Berkeley, California
    Multiple Sclerosis, Relapsing-Remitting
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Prostate Cancer, Sexual Dysfunction
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Lung Cancer
    Connect® MM- The Multiple Myeloma Disease Registry
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Breast Cancer
    Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis
    Alta Bates Summit Medical Center
    Berkeley, California 94704
    Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Kidney Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Hepatocellular Carcinoma
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Alta Bates Summit Medical Center-Herrick Campus
    Berkeley, California 94704
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma
    Alta Bates Summit Comprehensive Cancer Center
    Berkeley, California 94704
    Multiple Myeloma